ACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
On February 6, 2025, ACELYRIN announced an agreement to merge with Alumis Inc. (Nasdaq: ALMS) in an all-stock transaction. The transaction is expected to close in the second quarter of 2025, subject ...
SEC acknowledgment of 3 spot XRP ETF filings could trigger rally to $6 — Analyst
XRP(XRP) price has rallied more than 15% since closing at $2.32 on Feb. 6, following the crypto market’s drawdown. While most ...